Bill and Melinda Gates Foundation to focus on drugs, vaccine research
March 24th, 2011 - 8:15 pm ICT by ANINew Delhi, Mar. 24 (ANI): The Bill and Melinda Gates Foundation would focus on investing in drugs and vaccines for diseases like AIDS, malaria and tuberculosis, the billionaire philanthropist said here on Thursday.
Bill and Melinda Gates have committed themselves to healthcare and community work, especially in rural areas.
Addressing an event on public health concerns, Gates said his foundation would focus on these areas neglected by companies that eye just profits.
“Our focus is are diseases like Malaria, or TB (Tuberculosis) or AIDS (Acquired Immune Deficiency Syndrome) or trials of diseases whether it’s almost no research funding coming out from the profit companies, simply because there is no market for those diseases not large enough to justify the risks involved. And, so we have a particular aim and that’s what allowed a lot more TB drug discovery research, TB vaccine research, Malaria research. And in developing countries these infectious diseases are the primary thing that reduces life expectancy and so we’ll stay focused on those things because that’s where you have this unbelievable neglect,” he said.
The Foundation has so far given away 14.5 billion dollars in health grants to organisations worldwide.
The aims of the foundation through the grants are to discover new insights to fight diseases that affect developing countries. It also seeks to develop effective and affordable vaccines and medicines.
It has committed approximately a billion dollars for health projects in India.
The Gates Foundation’s India AIDS initiative ‘Avahan’ increased the commitment to 338 million dollars in 2009.
Gates said the foundation would especially back programmes to check TB.
“With TB, you know we look every year when we look at the number of deaths and we say it’s unacceptable and so we are backing drug work, vaccine work, diagnostic work. And, so for me it’s very similar I think my Microsoft experience prepared me well for the this foundation work and I’m always learning new things, getting out in the field to see what has impact. So, I’d say at least for me running the foundation is a lot like running a software foundation company
Gates and Melinda visited a village and interacted with people in Bihar on Wednesday.
They were on a daylong visit to inspect various philanthropic projects being carried out under the foundation.
They visited the Simraha and Jamsaut villages in the suburban Danapur area near Patna, and interacted with the locals there.
Bill and Melinda Gates met with some community health workers and state officials to launch a five-year 80 million dollar grant made in partnership with the state government. (ANI)
- China reports 900,000 TB cases in 2011 - Mar 21, 2012
- Bill Gates contributes $750 million to global AIDS fund - Jan 26, 2012
- US firm gets $220 mn Gates grant to combat TB - Mar 15, 2012
- Electronic Nose can sniff tuberculosis - Nov 06, 2011
- Azad, Bill Gates discuss ways to strengthen health scenario in India - Jul 24, 2009
- Hyderabad foundation gets $100,000 grant for polio vaccine - May 10, 2012
- GVK BIO to support global consortium - May 16, 2011
- Bill Gates and Melinda visit village in Bihar - Mar 23, 2011
- New tuberculosis (TB) Vaccine could be ready by 2020 - Jul 19, 2010
- Regulatory Conference Shows The Way Forward From Lessons Learnt In The Past - Aug 20, 2010
- Symposium shows progress in TB vaccines - Jun 08, 2010
- Bill, Melinda Gates donate $10bn for vaccines in developing countries - Jan 30, 2010
- 'India needs to step up vaccination to save its children' - Jun 11, 2011
- Should tuberculosis (TB)-preventive therapy (IPT) be given to all? - Aug 02, 2010
- Bill Gates to visit India this week - Mar 21, 2011
Tags: aids initiative, bill and melinda gates, bill and melinda gates foundation, billionaire philanthropist, diagnostic work, drug discovery research, health grants, health projects, immune deficiency syndrome, infectious diseases, malaria research, melinda gates foundation, microsoft experience, new insights, profit companies, public health concerns, research tb, tb vaccine, vaccine research, vaccine work